drugset / Trial / NCT00616330

Vaginal Infection Study

NCT00616330

Phase 3 Completed 1443 enrolled Lumara Health, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the efficacy and safety of a vaginal product compared with that of other vaginal products in the treatment of vaginal infections.

Timeline

Start
2008-01
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Butoconazole Small molecule
Comparator Clindamycin Unknown

Indications